BACKGROUND: Western breast cancer survivors have an increased risk of osteoporosis and bone fracture. Breast cancer occurs 10 to 20 years earlier in Asian women than in Western women. We investigated if younger Asian women with breast cancer also have increased risk of fracture. METHODS: We used the universal insurance claims data from 2000 to 2003 to identify 22,076 patients with breast cancer and 88,304 women without cancer, frequency matched with age and index date (the date for a health care visit). The incidence of fracture in both cohorts and the hazard ratios (HRs) of fracture in the cancer cohort were estimated by the end of 2009. RESULTS: The incidence of all types of fracture was higher in the breast cancer cohort than in the comp...
Background: Women diagnosed with breast cancer are at higher risk of osteoporosis and osteoporotic f...
Background Aromatase inhibitors (AIs) used in breast cancer induce loss in bone mineral density (BMD...
Background. Aromatase inhibitors (AIs) used in breast cancer induce loss in bone mineral density (B...
Western breast cancer survivors have an increased risk of osteoporosis and bone fracture. Breast can...
[[abstract]]BACKGROUND: Breast cancer survivors have an increased risk of bone fracture. But the ris...
Abstract Background Breast cancer survivors are at high risk for fracture due to cancer treatment-in...
OBJECTIVES: To examine the effect of breast cancer and its treatment on fracture risk in older breas...
AbstractPurposeWomen with breast cancer are at increased risk for femur fracture. Contributing facto...
Purpose: Women with breast cancer are at increased risk for femur fracture. Contributing factors inc...
Women with breast cancer, particularly individuals diagnosed at a relatively early age, have an incr...
Objective: To compare the osteoporosis awareness and its association with 10-year fracture risks bet...
SummaryObjectiveTo compare the osteoporosis awareness and its association with 10-year fracture risk...
Because treatment for breast cancer may adversely affect skeletal metabolism, we investigated verteb...
Fractures in postmenopausal women may serve as a surrogate measure of bone density, reflecting long-...
INTRODUCTION: Although the effect of hormonal therapy (HT) on fracture risk during treatment of brea...
Background: Women diagnosed with breast cancer are at higher risk of osteoporosis and osteoporotic f...
Background Aromatase inhibitors (AIs) used in breast cancer induce loss in bone mineral density (BMD...
Background. Aromatase inhibitors (AIs) used in breast cancer induce loss in bone mineral density (B...
Western breast cancer survivors have an increased risk of osteoporosis and bone fracture. Breast can...
[[abstract]]BACKGROUND: Breast cancer survivors have an increased risk of bone fracture. But the ris...
Abstract Background Breast cancer survivors are at high risk for fracture due to cancer treatment-in...
OBJECTIVES: To examine the effect of breast cancer and its treatment on fracture risk in older breas...
AbstractPurposeWomen with breast cancer are at increased risk for femur fracture. Contributing facto...
Purpose: Women with breast cancer are at increased risk for femur fracture. Contributing factors inc...
Women with breast cancer, particularly individuals diagnosed at a relatively early age, have an incr...
Objective: To compare the osteoporosis awareness and its association with 10-year fracture risks bet...
SummaryObjectiveTo compare the osteoporosis awareness and its association with 10-year fracture risk...
Because treatment for breast cancer may adversely affect skeletal metabolism, we investigated verteb...
Fractures in postmenopausal women may serve as a surrogate measure of bone density, reflecting long-...
INTRODUCTION: Although the effect of hormonal therapy (HT) on fracture risk during treatment of brea...
Background: Women diagnosed with breast cancer are at higher risk of osteoporosis and osteoporotic f...
Background Aromatase inhibitors (AIs) used in breast cancer induce loss in bone mineral density (BMD...
Background. Aromatase inhibitors (AIs) used in breast cancer induce loss in bone mineral density (B...